FOXA1 loss drives basal/squamous de-differentiation of prostate cancer and induces an immunosuppressive tumor microenvironment

L Lourdes Brea H Hongshun Shi V Viriya Keo J Jing Huang L Liu Peng Q Qi Chu (School of Biomedical Sciences and Engineering, South China University of Technology, Guangzhou International Campus) W Wanqing Xie Y Yinghua Xie S Sambhavi Senthil M Matthew T. Breneman J Jie Fan (Zhejiang Key Laboratory of Low-Carbon Synthesis of Value-Added Chemicals, State Key Laboratory of Soil Pollution Control and Safety, Department of Chemistry) P Ping Xie (State Key Laboratory of Chemo and Biosensing, College of Chemistry and Chemical Engineering) X Xiaodong Lu D David J. Degraff S Sarki A. Abdulkadir X Ximing Yang D David Kosoff J Jonathan C. Zhao B Bin Zhang J Jian Hu J Jindan Yu

Abstract

Abstract FOXA1 is a prostate lineage-specifying transcription factor that is frequently dysregulated or mutated in prostate cancer (PCa). While FOXA1 has been reported to exhibit both PCa-promoting and -inhibitory functions, its role within an immune-proficient PCa context remains unclear. Here, we show that prostate-specific deletion of Foxa1 in Pten -deficient mice drives tumor progression by reprogramming luminal PCa cells toward a basal/squamous-like state and promoting an immunosuppressive tumor microenvironment. Histological and transcriptomic analyses reveal aggressive tumors with extensive basal/squamous features, a reactive stroma, and disorganized tissue architecture. Mechanistically, FOXA1 directly represses basal/squamous and inflammatory genes, which become activated upon its depletion. This is accompanied by an accumulation of immunosuppressive myeloid cells, dysfunctional T cells, and immunosuppressive cytokine signaling. Together, these findings demonstrate a tumor-suppressive role for FOXA1 as an enforcer of luminal identity, such that its loss drives basal/squamous de-differentiation, inflammatory response, and immunosuppression.

Article Details

Volume / Issue Vol. 17, Issue 1
Published March 28, 2026
ISSN 2041-1723
Publisher Nature Portfolio

Journal Info

Nature Communications

Nature Portfolio

ISSN: 2041-1723 Open Access Life Sciences

Authors (21)

L

Lourdes Brea

H

Hongshun Shi

V

Viriya Keo

J

Jing Huang

L

Liu Peng

Q

Qi Chu

School of Biomedical Sciences and Engineering, South China University of Technology, Guangzhou International Campus

W

Wanqing Xie

Y

Yinghua Xie

S

Sambhavi Senthil

M

Matthew T. Breneman

J

Jie Fan

Zhejiang Key Laboratory of Low-Carbon Synthesis of Value-Added Chemicals, State Key Laboratory of Soil Pollution Control and Safety, Department of Chemistry

P

Ping Xie

State Key Laboratory of Chemo and Biosensing, College of Chemistry and Chemical Engineering

X

Xiaodong Lu

D

David J. Degraff

S

Sarki A. Abdulkadir

X

Ximing Yang

D

David Kosoff

J

Jonathan C. Zhao

B

Bin Zhang

J

Jian Hu

J

Jindan Yu